In an all-cash transaction, RIL pays Rs 375 cr to purchase healthcare company Karkinos.

Reliance Industries, owned by billionaire Mukesh Ambani, announced on Saturday that it has paid Rs 375 crore to acquire Karkinos, a technology-driven healthcare platform with an oncology focus.In a stock exchange filing, Reliance Strategic Business Ventures (RSBVL), a wholly-owned subsidiary of the most valuable corporation in India listed on the Mumbai Stock Exchange, announced that it had successfully acquired Karkinos Healthcare Pvt Ltd and allocated the necessary shares.

Karkinos was founded in India on July 24, 2020, and offers cutting-edge, technology-driven solutions for cancer diagnosis, treatment, and early detection. In the fiscal year 2022–2023, it generated approximately Rs 22 crore in revenue."Reliance Strategic Business Ventures Ltd has on December 27, 2024, subscribed to and has been allotted 10 mn equity shares of Rs 10 each, for cash, aggregating Rs 10 crore and 365 million optionally fully convertible debentures of Rs 10 each, for cash, aggregating Rs 365 crore of Karkinos," according to the regulatory filing.